Cargando…

OX40 is required for regulatory T cell–mediated control of colitis

The immune response in the gastrointestinal tract is a tightly controlled balance between effector and regulatory cell responses. Here, we have investigated the role of OX40 in influencing the balance between conventional T cells and Foxp3(+) regulatory T (T reg) cells. Under steady-state conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Griseri, Thibault, Asquith, Mark, Thompson, Claire, Powrie, Fiona
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856021/
https://www.ncbi.nlm.nih.gov/pubmed/20368580
http://dx.doi.org/10.1084/jem.20091618
_version_ 1782180228191223808
author Griseri, Thibault
Asquith, Mark
Thompson, Claire
Powrie, Fiona
author_facet Griseri, Thibault
Asquith, Mark
Thompson, Claire
Powrie, Fiona
author_sort Griseri, Thibault
collection PubMed
description The immune response in the gastrointestinal tract is a tightly controlled balance between effector and regulatory cell responses. Here, we have investigated the role of OX40 in influencing the balance between conventional T cells and Foxp3(+) regulatory T (T reg) cells. Under steady-state conditions, OX40 was required by T reg cells for their accumulation in the colon, but not peripheral lymphoid organs. Strikingly, under inflammatory conditions OX40 played an essential role in T reg cell–mediated suppression of colitis. OX40(−/−) T reg cells showed reduced accumulation in the colon and peripheral lymphoid organs, resulting in their inability to keep pace with the effector response. In the absence of OX40 signaling, T reg cells underwent enhanced activation-induced cell death, indicating that OX40 delivers an important survival signal to T reg cells after activation. As OX40 also promoted the colitogenic Th1 response, its expression on T reg cells may be required for effective competition with OX40-dependent effector responses. These results newly identify a key role for OX40 in the homeostasis of intestinal Foxp3 (+)T reg cells and in suppression of colitis. These fi ndings should be taken into account when considering OX40 blockade for treatment of IBD.
format Text
id pubmed-2856021
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-28560212010-10-12 OX40 is required for regulatory T cell–mediated control of colitis Griseri, Thibault Asquith, Mark Thompson, Claire Powrie, Fiona J Exp Med Brief Definitive Report The immune response in the gastrointestinal tract is a tightly controlled balance between effector and regulatory cell responses. Here, we have investigated the role of OX40 in influencing the balance between conventional T cells and Foxp3(+) regulatory T (T reg) cells. Under steady-state conditions, OX40 was required by T reg cells for their accumulation in the colon, but not peripheral lymphoid organs. Strikingly, under inflammatory conditions OX40 played an essential role in T reg cell–mediated suppression of colitis. OX40(−/−) T reg cells showed reduced accumulation in the colon and peripheral lymphoid organs, resulting in their inability to keep pace with the effector response. In the absence of OX40 signaling, T reg cells underwent enhanced activation-induced cell death, indicating that OX40 delivers an important survival signal to T reg cells after activation. As OX40 also promoted the colitogenic Th1 response, its expression on T reg cells may be required for effective competition with OX40-dependent effector responses. These results newly identify a key role for OX40 in the homeostasis of intestinal Foxp3 (+)T reg cells and in suppression of colitis. These fi ndings should be taken into account when considering OX40 blockade for treatment of IBD. The Rockefeller University Press 2010-04-12 /pmc/articles/PMC2856021/ /pubmed/20368580 http://dx.doi.org/10.1084/jem.20091618 Text en © 2010 Griseri et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Brief Definitive Report
Griseri, Thibault
Asquith, Mark
Thompson, Claire
Powrie, Fiona
OX40 is required for regulatory T cell–mediated control of colitis
title OX40 is required for regulatory T cell–mediated control of colitis
title_full OX40 is required for regulatory T cell–mediated control of colitis
title_fullStr OX40 is required for regulatory T cell–mediated control of colitis
title_full_unstemmed OX40 is required for regulatory T cell–mediated control of colitis
title_short OX40 is required for regulatory T cell–mediated control of colitis
title_sort ox40 is required for regulatory t cell–mediated control of colitis
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856021/
https://www.ncbi.nlm.nih.gov/pubmed/20368580
http://dx.doi.org/10.1084/jem.20091618
work_keys_str_mv AT griserithibault ox40isrequiredforregulatorytcellmediatedcontrolofcolitis
AT asquithmark ox40isrequiredforregulatorytcellmediatedcontrolofcolitis
AT thompsonclaire ox40isrequiredforregulatorytcellmediatedcontrolofcolitis
AT powriefiona ox40isrequiredforregulatorytcellmediatedcontrolofcolitis